XENON PHARMACEUTICALS INC (XENE) Stock Earnings & Estimates
NASDAQ:XENE - CA98420N1050 - Common Stock
38.64 USD
-0.19 (-0.49%)
38.64 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 32.17M 371.01% | 18.44M -42.68% | 9.43M -48.86% | 2.11M -100.00% | 300.002K | 7.56M | 26.939M 256.34% | 101.63M 277.26% | 367.73M 261.83% | 725.7M 97.35% | 1.153B 58.88% | 1.312B 13.79% | 1.649B 25.69% | |
| EBITDA YoY % growth | -30.66M 27.67% | -78.08M -154.66% | -127.52M -63.32% | -214.333M -66.24% | -279.2M -30.54% | -339.502M -22.68% | -401.423M -18.24% | -345.145M 14.02% | -275.753M 20.11% | -45.04M 83.67% | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.3M 26.90% | -78.99M -152.36% | -129.14M -63.49% | -218.198M -65.75% | -280.316M -30.48% | -367.641M -31.63% | -411.631M -11.97% | -411.442M 0.05% | -206.695M 49.76% | 80.327M 138.86% | 358.5M 346.30% | 514.63M 43.55% | 798.14M 55.09% | |
| Operating Margin | -97.30% | -428.36% | -1,369.46% | -10,341.13% | -93,437.77% | -4,862.98% | -1,528.01% | -404.84% | -56.21% | 11.07% | 31.09% | 39.22% | 48.40% | |
| EPS YoY % growth | -0.81 47.40% | -1.77 -118.52% | -2.04 -15.25% | -2.91 -33.33% | -3.17 -11.03% | -4.29 -42.00% | -4.70 -9.69% | -4.59 2.41% | -3.63 21.01% | -0.72 80.09% | 1.74 341.13% | 4.07 133.78% | 6.54 60.69% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.17 -44.37% | -1.23 -46.46% | -1.14 -37.02% | -1.19 -11.63% | -1.23 -5.22% | -1.30 -5.40% | -1.37 -20.18% | -1.45 -21.26% | -1.43 -16.06% | -1.42 -9.34% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -98.144M -36.79% | -100.453M -34.09% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -98.247M -33.35% | -102.71M -32.57% | -99.884M -37.32% | -103.76M -10.11% | -108.282M -10.21% | -113.895M -10.89% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.07 -42.67% | -1.01 | -0.06 | -5.82% |
| Q1 2025 Q2Q % growth | -0.83 -33.87% | -0.93 | 0.10 | 10.75% |
| Q4 2024 Q2Q % growth | -0.84 -31.25% | -0.88 | 0.04 | 4.31% |
| Q3 2024 Q2Q % growth | -0.81 -10.96% | -0.83 | 0.02 | 2.60% |
| Q2 2024 Q2Q % growth | -0.75 -4.17% | -0.71 | -0.04 | -5.10% |
| Q1 2024 Q2Q % growth | -0.62 1.59% | -0.68 | 0.06 | 8.49% |
| Q4 2023 Q2Q % growth | -0.64 -12.28% | -0.77 | 0.13 | 17.35% |
| Q3 2023 Q2Q % growth | -0.73 -28.07% | -0.79 | 0.06 | 7.55% |
| Q2 2023 Q2Q % growth | -0.72 -30.91% | -0.71 | -0.01 | -1.23% |
| Q1 2023 Q2Q % growth | -0.63 -80.00% | -0.63 | 0.00 | 0.64% |
| Q4 2022 Q2Q % growth | -0.57 -18.75% | -0.60 | 0.03 | 4.45% |
| Q3 2022 Q2Q % growth | -0.57 -58.33% | -0.53 | -0.04 | -8.16% |
| Q2 2022 Q2Q % growth | -0.55 -7.84% | -0.49 | -0.06 | -11.64% |
| Q1 2022 Q2Q % growth | -0.35 16.67% | -0.41 | 0.06 | 15.39% |
| Q4 2021 Q2Q % growth | -0.48 -41.18% | -0.38 | -0.10 | -26.96% |
| Q3 2021 Q2Q % growth | -0.36 -44.00% | -0.39 | 0.03 | 7.93% |
| Q2 2021 Q2Q % growth | -0.51 | -0.49 | -0.02 | -4.44% |
| Q1 2021 Q2Q % growth | -0.42 -90.91% | -0.44 | 0.02 | 4.79% |
| Q4 2020 Q2Q % growth | -0.34 19.05% | -0.41 | 0.07 | 16.61% |
| Q3 2020 Q2Q % growth | -0.25 24.24% | -0.15 | -0.10 | -61.86% |
| Q2 2020 Q2Q % growth | 0.00 100.00% | -0.24 | 0.24 | 100.00% |
| Q1 2020 Q2Q % growth | -0.22 47.62% | -0.33 | 0.11 | 33.06% |
| Q4 2019 Q2Q % growth | -0.42 | -0.49 | 0.07 | 14.81% |
| Q3 2019 Q2Q % growth | -0.33 | -0.49 | 0.16 | 32.95% |
| Q2 2019 Q2Q % growth | -0.37 | -0.47 | 0.10 | 21.14% |
| Q1 2019 Q2Q % growth | -0.42 | -0.37 | -0.05 | -14.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 7.5M | 1.129M | 6.371M | 564.30% |
| Q4 2024 Q2Q % growth | 339.997K | -339.997K | -100.00% | |
| Q4 2023 Q2Q % growth | 1.93M | -1.93M | -100.00% | |
| Q3 2023 Q2Q % growth | -100.00% | 1.479M | -1.479M | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | 408K | -408K | -100.00% |
| Q1 2023 Q2Q % growth | -100.00% | 582.859K | -582.859K | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | 2.329M | -2.329M | -100.00% |
| Q3 2022 Q2Q % growth | 130K -98.40% | 3.079M | -2.949M | -95.78% |
| Q2 2022 Q2Q % growth | 540K -75.68% | 3.626M | -3.086M | -85.11% |
| Q1 2022 Q2Q % growth | 8.77M 101.15% | 8.874M | -104K | -1.17% |
| Q4 2021 Q2Q % growth | 3.74M -27.38% | 5.075M | -1.335M | -26.31% |
| Q3 2021 Q2Q % growth | 8.12M 23.97% | 10.43M | -2.31M | -22.15% |
| Q2 2021 Q2Q % growth | 2.22M -83.41% | 2.375M | -155K | -6.53% |
| Q1 2021 Q2Q % growth | 4.36M -38.42% | 3.026M | 1.334M | 44.08% |
| Q4 2020 Q2Q % growth | 5.15M 54.65% | 3.28M | 1.87M | 57.01% |
| Q3 2020 Q2Q % growth | 6.55M 87.14% | 10.257M | -3.707M | -36.14% |
| Q2 2020 Q2Q % growth | 13.38M | 7.037M | 6.343M | 90.14% |
| Q1 2020 Q2Q % growth | 7.08M | 4.59M | 2.49M | 54.25% |
| Q4 2019 Q2Q % growth | 3.33M | 5.1M | -1.77M | -34.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.89% | -17.08% | -4.66% | -4.4% |
| Revenue | N/A | N/A | 5.88% | 81.03% |